Hims, Lilly sign obesity-drug pact for Zepbound, Foundayo telehealth at $149, $299 self-pay

 

Hims & Hers, Eli Lilly sign obesity-drug pact to offer Zepbound and Foundayo via telehealth at $149 and $299 self-pay prices

• Hims & Hers commits not to sell compounded copies of Eli Lilly’s GLP-1 obesity medicines.
• Drugs will be offered at Eli Lilly’s self-pay prices, expanding GLP-1 access for Hims & Hers weight-loss customers.

https://finviz.com/stock?t=HIMS&p=d